Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Scorza

Showing results (171-180 of 185) with videos related to

Pageof 19
Sort By:
The Journal of Rheumatology|January 27, 2000
Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: clinical, serological, and HLA class II gene associations. European Concerted Action on the Immunogenetics of SLEM Galeazzi, P Annunziata, G D Sebastiani, et al.
Arthritis and Rheumatism|February 5, 2005
Two single-nucleotide polymorphisms in the 5' and 3' ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosusS D'Alfonso, N Barizzone, M Giordano, et al.
Genes and Immunity|May 4, 2012
Evidence that deletion at FCGR3B is a risk factor for systemic sclerosisC McKinney, J C A Broen, M C Vonk, et al.
Rheumatology (Oxford, England)|December 7, 2002
Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patientsR Gerli, L Caponi, A Tincani, et al.
Lupus|February 20, 1999
Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestationsM G Sabbadini, A A Manfredi, E Bozzolo, et al.
Annals of the Rheumatic Diseases|May 15, 2001
European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centresA Della Rossa, G Valentini, S Bombardieri, et al.
Arthritis and Rheumatism|September 10, 2011
A rare polymorphism in the gene for Toll-like receptor 2 is associated with systemic sclerosis phenotype and increases the production of inflammatory mediatorsJ C A Broen, L Bossini-Castillo, L van Bon, et al.
Annals of the Rheumatic Diseases|May 15, 2001
European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexesG Valentini, A Della Rossa, S Bombardieri, et al.
Genes and Immunity|June 15, 2007
Opposed independent effects and epistasis in the complex association of IRF5 to SLEI Ferreiro-Neira, M Calaza, E Alonso-Perez, et al.
Human Molecular Genetics|March 17, 2009
The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotypeB Rueda, J Broen, C Simeon, et al.
Pageof 19

Showing results (171-180 of 185) with videos related to

Sort By:
Pageof 19
The Journal of Rheumatology|January 27, 2000
Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: clinical, serological, and HLA class II gene associations. European Concerted Action on the Immunogenetics of SLEM Galeazzi, P Annunziata, G D Sebastiani, et al.
Arthritis and Rheumatism|February 5, 2005
Two single-nucleotide polymorphisms in the 5' and 3' ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosusS D'Alfonso, N Barizzone, M Giordano, et al.
Genes and Immunity|May 4, 2012
Evidence that deletion at FCGR3B is a risk factor for systemic sclerosisC McKinney, J C A Broen, M C Vonk, et al.
Rheumatology (Oxford, England)|December 7, 2002
Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patientsR Gerli, L Caponi, A Tincani, et al.
Lupus|February 20, 1999
Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestationsM G Sabbadini, A A Manfredi, E Bozzolo, et al.
Annals of the Rheumatic Diseases|May 15, 2001
European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centresA Della Rossa, G Valentini, S Bombardieri, et al.
Arthritis and Rheumatism|September 10, 2011
A rare polymorphism in the gene for Toll-like receptor 2 is associated with systemic sclerosis phenotype and increases the production of inflammatory mediatorsJ C A Broen, L Bossini-Castillo, L van Bon, et al.
Annals of the Rheumatic Diseases|May 15, 2001
European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexesG Valentini, A Della Rossa, S Bombardieri, et al.
Genes and Immunity|June 15, 2007
Opposed independent effects and epistasis in the complex association of IRF5 to SLEI Ferreiro-Neira, M Calaza, E Alonso-Perez, et al.
Human Molecular Genetics|March 17, 2009
The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotypeB Rueda, J Broen, C Simeon, et al.
Pageof 19